FIFRA Scientific Advisory Panel; Notice of Public Meeting, 12311-12313 [2013-03977]
Download as PDF
Federal Register / Vol. 78, No. 36 / Friday, February 22, 2013 / Notices
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2013–0075; FRL–9378–8]
FIFRA Scientific Advisory Panel;
Notice of Public Meeting
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
There will be a 4-day meeting
of the Federal Insecticide, Fungicide,
and Rodenticide Act Scientific Advisory
Panel (FIFRA SAP) to consider and
review the Endocrine Disruptor
Screening Program (EDSP) Tier 1
Screening Assays and Battery
Performance.
SUMMARY:
The meeting will be held on May
21–24, 2013, from approximately 9 a.m.
to 5 p.m.
Comments. The Agency encourages
that written comments be submitted by
May 7, 2013 and requests for oral
comments be submitted by May 14,
2013. However, written comments and
requests to make oral comments may be
submitted until the date of the meeting,
but anyone submitting written
comments after May 7, 2013 should
contact the Designated Federal Official
(DFO) listed under FOR FURTHER
INFORMATION CONTACT. For additional
instructions, see Unit I.C. of the
SUPPLEMENTARY INFORMATION.
Nominations. Nominations of
candidates to serve as ad hoc members
of FIFRA SAP for this meeting should
be provided on or before March 8, 2013.
Webcast. This meeting may be
webcast. Please refer to the FIFRA SAP’s
Web site, https://www.epa.gov/scipoly/
sap for information on how to access the
webcast. Please note that the webcast is
a supplementary public process
provided only for convenience. If
difficulties arise resulting in webcasting
outages, the meeting will continue as
planned.
Special accommodations. For
information on access or services for
individuals with disabilities, and to
request accommodation of a disability,
please contact the DFO listed under FOR
FURTHER INFORMATION CONTACT at least
10 days prior to the meeting to give EPA
as much time as possible to process
your request.
ADDRESSES: The meeting will be held at
the Environmental Protection Agency,
Conference Center, Lobby Level, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA 22202.
Comments. Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2013–0075, by
one of the following methods:
sroberts on DSK5SPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
16:18 Feb 21, 2013
Jkt 229001
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.,
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.htm.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
If your comments contain any
information that you consider to be CBI
or otherwise protected, please contact
the DFO listed under FOR FURTHER
INFORMATION CONTACT to obtain special
instructions before submitting your
comments.
Nominations, requests to present oral
comments, and requests for special
accommodations. Submit nominations
to serve as ad hoc members of FIFRA
SAP, requests for special seating
accommodations, or requests to present
oral comments to the DFO listed under
FOR FURTHER INFORMATION CONTACT.
FOR FURTHER INFORMATION CONTACT: Fred
Jenkins Jr., DFO, Office of Science
Coordination and Policy (7201M),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(202) 564–3327; fax number: (202) 564–
8382; email address:
jenkins.fred@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general. This action may, however, be
of interest to persons who are or may be
required to conduct testing of chemical
substances under the Federal Food,
Drug, and Cosmetic Act (FFDCA) and
FIFRA. Since other entities may also be
interested, the Agency has not
attempted to describe all the specific
entities that may be affected by this
action.
B. What should I consider as I prepare
my comments for EPA?
When submitting comments,
remember to:
1. Identify the document by docket ID
number and other identifying
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
12311
information (subject heading, Federal
Register date and page number).
2. Follow directions. The Agency may
ask you to respond to specific questions
or organize comments by referencing a
Code of Federal Regulations (CFR) part
or section number.
3. Explain why you agree or disagree;
suggest alternatives and substitute
language for your requested changes.
4. Describe any assumptions and
provide any technical information and/
or data that you used.
5. If you estimate potential costs or
burdens, explain how you arrived at
your estimate in sufficient detail to
allow for it to be reproduced.
6. Provide specific examples to
illustrate your concerns and suggest
alternatives.
7. Explain your views as clearly as
possible, avoiding the use of profanity
or personal threats.
8. Make sure to submit your
comments by the comment period
deadline identified.
C. How may I participate in this
meeting?
You may participate in this meeting
by following the instructions in this
unit. To ensure proper receipt by EPA,
it is imperative that you identify docket
ID number EPA–HQ–OPP–2013–0075 in
the subject line on the first page of your
request.
1. Written comments. The Agency
encourages that written comments be
submitted, using the instructions in
ADDRESSES, no later than May 7, 2013,
to provide FIFRA SAP the time
necessary to consider and review the
written comments. Written comments
are accepted until the date of the
meeting, but anyone submitting written
comments after May 7, 2013 should
contact the DFO listed under FOR
FURTHER INFORMATION CONTACT. Anyone
submitting written comments at the
meeting should bring 25 copies for
distribution to FIFRA SAP.
2. Oral comments. The Agency
encourages that each individual or
group wishing to make brief oral
comments to FIFRA SAP submit their
request to the DFO listed under FOR
FURTHER INFORMATION CONTACT no later
than May 14, 2013, in order to be
included on the meeting agenda.
Requests to present oral comments will
be accepted until the date of the meeting
and, to the extent that time permits, the
Chair of FIFRA SAP may permit the
presentation of oral comments at the
meeting by interested persons who have
not previously requested time. The
request should identify the name of the
individual making the presentation, the
organization (if any) the individual will
E:\FR\FM\22FEN1.SGM
22FEN1
sroberts on DSK5SPTVN1PROD with NOTICES
12312
Federal Register / Vol. 78, No. 36 / Friday, February 22, 2013 / Notices
represent, and any requirements for
audiovisual equipment (e.g., overhead
projector, 35 mm projector). Oral
comments before FIFRA SAP are limited
to approximately 5 minutes unless prior
arrangements have been made. In
addition, each speaker should bring 25
copies of his or her comments and
presentation slides for distribution to
the FIFRA SAP at the meeting.
3. Seating at the meeting. Seating at
the meeting will be open and on a firstcome basis.
4. Request for nominations to serve as
ad hoc members of FIFRA SAP for this
meeting. As part of a broader process for
developing a pool of candidates for each
meeting, FIFRA SAP staff routinely
solicits the stakeholder community for
nominations of prospective candidates
for service as ad hoc members of FIFRA
SAP. Any interested person or
organization may nominate qualified
individuals to be considered as
prospective candidates for a specific
meeting. Individuals nominated for this
meeting should have expertise in one or
more of the following areas: Regulatory
toxicology/risk assessment,
ecotoxicology (fish and amphibian
toxicology), comparative endocrinology,
reproductive physiology, developmental
biology/toxicology, thyroid physiology,
in vitro models, toxicological pathology,
amphibian histopathology,
morphometrics, quantitative ecology/
biostatistics, and systems biology.
Nominees should be scientists who have
sufficient professional qualifications,
including training and experience, to be
capable of providing expert comments
on the scientific issues for this meeting.
Nominees should be identified by name,
occupation, position, address, and
telephone number. Nominations should
be provided to the DFO listed under FOR
FURTHER INFORMATION CONTACT on or
before March 8, 2013. The Agency will
consider all nominations of prospective
candidates for this meeting that are
received on or before this date.
However, final selection of ad hoc
members for this meeting is a
discretionary function of the Agency.
The selection of scientists to serve on
FIFRA SAP is based on the function of
the panel and the expertise needed to
address the Agency’s charge to the
panel. No interested scientists shall be
ineligible to serve by reason of their
membership on any other advisory
committee to a Federal department or
agency or their employment by a
Federal department or agency except the
EPA. Other factors considered during
the selection process include
availability of the potential panel
member to fully participate in the
panel’s reviews, absence of any conflicts
VerDate Mar<15>2010
16:18 Feb 21, 2013
Jkt 229001
of interest or appearance of lack of
impartiality, independence with respect
to the matters under review, and lack of
bias. Although financial conflicts of
interest, the appearance of lack of
impartiality, lack of independence, and
bias may result in disqualification, the
absence of such concerns does not
assure that a candidate will be selected
to serve on FIFRA SAP. Numerous
qualified candidates are identified for
each panel. Therefore, selection
decisions involve carefully weighing a
number of factors including the
candidates’ areas of expertise and
professional qualifications and
achieving an overall balance of different
scientific perspectives on the panel. In
order to have the collective breadth of
experience needed to address the
Agency’s charge for this meeting, the
Agency anticipates selecting
approximately 10 ad hoc scientists.
FIFRA SAP members are subject to
the provisions of 5 CFR part 2634,
Executive Branch Financial Disclosure,
as supplemented by the EPA in 5 CFR
part 6401. In anticipation of this
requirement, prospective candidates for
service on the FIFRA SAP will be asked
to submit confidential financial
information which shall fully disclose,
among other financial interests, the
candidate’s employment, stocks and
bonds, and where applicable, sources of
research support. The EPA will evaluate
the candidates financial disclosure form
to assess whether there are financial
conflicts of interest, appearance of a
lack of impartiality or any prior
involvement with the development of
the documents under consideration
(including previous scientific peer
review) before the candidate is
considered further for service on FIFRA
SAP. Those who are selected from the
pool of prospective candidates will be
asked to attend the public meetings and
to participate in the discussion of key
issues and assumptions at these
meetings. In addition, they will be asked
to review and to help finalize the
meeting minutes. The list of FIFRA SAP
members participating at this meeting
will be posted on the FIFRA SAP Web
site at https://www.epa.gov/scipoly/sap
or may be obtained from the OPP Docket
or at https://www.regulations.gov.
II. Background
A. Purpose of FIFRA SAP
FIFRA SAP serves as the primary
scientific peer review mechanism of
EPA’s Office of Chemical Safety and
Pollution Prevention (OCSPP) and is
structured to provide scientific advice,
information and recommendations to
the EPA Administrator on pesticides
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
and pesticide-related issues as to the
impact of regulatory actions on health
and the environment. FIFRA SAP is a
Federal advisory committee established
in 1975 under FIFRA that operates in
accordance with requirements of the
Federal Advisory Committee Act. FIFRA
SAP is composed of a permanent panel
consisting of seven members who are
appointed by the EPA Administrator
from nominees provided by the National
Institutes of Health and the National
Science Foundation. FIFRA established
a Science Review Board consisting of at
least 60 scientists who are available to
the SAP on an ad hoc basis to assist in
reviews conducted by the SAP. As a
peer review mechanism, FIFRA SAP
provides comments, evaluations and
recommendations to improve the
effectiveness and quality of analyses
made by Agency scientists. Members of
FIFRA SAP are scientists who have
sufficient professional qualifications,
including training and experience, to
provide expert advice and
recommendation to the Agency.
B. Public Meeting
Under the Federal Food, Drug, and
Cosmetic Act (FFDCA), section 408(p)
and the Safe Drinking Water Act
(SDWA), section 1457, the EPA is
required to screen all pesticide
chemicals (active and inert ingredients)
and those drinking water contaminants
to which a ‘‘substantial population’’ is
exposed for the potential to interact
with the endocrine system. As
recommended by a Federal Advisory
Committee, (Endocrine Disruptor
Screening and Testing Advisory
Committee, EDSTAC), the EPA
Endocrine Disruptor Screening Program
(EDSP) established a two tiered
screening and testing program to
address the potential of chemicals to
perturb the estrogen, androgen or
thyroid (E,A or T) systems and elicit
adverse human and ecological health
outcomes. In 1999, following the
EDSTAC recommendations, a joint
subcommittee of the Agency’s Science
Advisory Board (SAB) and FIFRA SAP
recommended to the Agency, after
review of the initial set of Tier 1 data,
to subject that data to external scientific
peer review for consideration to further
optimize the Tier 1 screening battery.
Tier 1 screening was recommended to
include a diverse yet complementary
suite of in vitro and in vivo assays
covering multiple hormonal modes of
action (MoA) across various taxa. To
maximize sensitivity and reliability (i.e.,
minimizing false negatives) for
determining the potential of a chemical
to interact with E, A, or T, the suite of
assays was to be conducted as a battery.
E:\FR\FM\22FEN1.SGM
22FEN1
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 36 / Friday, February 22, 2013 / Notices
If the results of the Tier 1 battery
indicated the potential for a chemical to
interact with the endocrine system as
determined through a weight of
evidence (WoE) analysis, various Tier 2
tests were to be considered for
determining dose-response relationships
and any potential adverse effects for risk
assessment. The EDSP is mandated
under FFDCA to use ‘‘validated’’ assays
to screen for endocrine disrupting
chemicals. Validation principles
established by the Organization for
Economic Co-Operation and
Development (OECD) and Interagency
Coordinating Committee on the
Validation of Alternative Methods
(ICCVAM) were followed to develop,
standardize, and validate many of the
initially proposed Tier 1 in vitro and in
vivo screening assays as well as more
novel screening assays that emerged
after the EDSTAC final report in 1998.
Subsequent to the validation process, an
independent peer review of individual
Tier 1 screening assays was conducted.
Based on results of the validation
process, comments from peer review,
and recommendations from EDSTAC,
the EDSP proposed a battery of
screening assays that was founded on
the strengths of one or more assays
complimenting the limitations of other
assays in the battery. Moreover, it was
expected that the result(s) of each assay
would not be considered in isolation but
be inclusive of the results of all assays
in the battery to support a WoE analysis.
The FIFRA SAP reviewed the proposed
Tier 1 screening battery and
recommended a battery of 11 assays to
EPA which the Panel indicated ‘‘* * *
as an appropriate starting point to detect
endocrine disrupting chemicals based
on the current state of the science.’’ In
addition, however, the SAP also
expected the Agency to continue ‘‘* * *
to develop, refine, and review the
battery.’’ Notably, this latter statement
concurs with a recommendation from
the initial joint SAB/SAP who indicated
EPA should review the initial data
‘‘* * * with an eye towards revising the
process and eliminating those methods
that don’t work.’’
This FIFRA SAP review will be
focused on a subset of the initial Tier 1
screening data received by the Agency
in response to test orders issued for the
first list of chemicals in 2009. The SAP
review will involve the performance of
the 11 Tier 1 screening assays and
performance of the assays as a battery
that was designed to detect the potential
of a test chemical to interact with the E,
A or T hormonal pathways. The SAP
will be asked to comment on factors that
may impact interpretation of the assay/
VerDate Mar<15>2010
16:18 Feb 21, 2013
Jkt 229001
battery results (e.g., variability) as well
as suggestions for increasing the
efficiency of the Tier 1 screening
approach. To illustrate assay/battery
performances, case examples of Tier 1
data from the initial list of chemicals
will be used. It should be noted that
there will be a separate SAP meeting
scheduled in the summer of 2013 to
discuss the decision logic in a WoE
approach to identify candidate
chemicals for Tier 2 testing using EDSP
Tier 1 screening results, other
scientifically relevant information
(OSRI), and health and ecological effects
data from 40 CFR part 158 studies.
C. FIFRA SAP Documents and Meeting
Minutes
EPA’s background paper, related
supporting materials, charge/questions
to FIFRA SAP, FIFRA SAP composition
(i.e., members and ad hoc members for
this meeting), and the meeting agenda
will be available by approximately early
May 2013. In addition, the Agency may
provide additional background
documents as the materials become
available. You may obtain electronic
copies of these documents, and certain
other related documents that might be
available electronically, at https://
www.regulations.gov and the FIFRA
SAP homepage at https://www.epa.gov/
scipoly/sap.
FIFRA SAP will prepare meeting
minutes summarizing its
recommendations to the Agency
approximately 90 days after the
meeting. The meeting minutes will be
posted on the FIFRA SAP Web site or
may be obtained from the OPP Docket
or at https://www.regulations.gov.
List of Subjects
Environmental protection, Pesticides
and pests, and Endocrine disruptors.
Dated: February 13, 2013.
Steven M. Knott,
Acting, Director, Office of Science
Coordination and Policy.
[FR Doc. 2013–03977 Filed 2–21–13; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2010–0014; FRL–9378–7]
Notice of Receipt of Requests To
Voluntarily Cancel Certain Pesticide
Registrations
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Insecticide, Fungicide, and
SUMMARY:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
12313
Rodenticide Act (FIFRA), EPA is issuing
a notice of receipt of requests by
registrants to voluntarily cancel certain
pesticide registrations. EPA intends to
grant these requests at the close of the
comment period for this announcement
unless the Agency receives substantive
comments within the comment period
that would merit its further review of
the requests, or unless the registrants
withdraw its requests. If these requests
are granted, any sale, distribution, or
use of products listed in this notice will
be permitted after the registration has
been cancelled only if such sale,
distribution, or use is consistent with
the terms as described in the final order.
DATES: Comments must be received on
or before August 21, 2013.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2010–0014, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
Submit written withdrawal request by
mail to: Pesticide Re-Evaluation
Division (7508P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460–0001. ATTN:
John W. Pates, Jr.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.htm.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at
https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: John
W. Pates, Jr., Pesticide Re-Evaluation
Division (7508P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460–0001; telephone
number: (703) 308–8195; email address:
pates.john@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general, and may be of interest to a
wide range of stakeholders including
E:\FR\FM\22FEN1.SGM
22FEN1
Agencies
[Federal Register Volume 78, Number 36 (Friday, February 22, 2013)]
[Notices]
[Pages 12311-12313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03977]
[[Page 12311]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2013-0075; FRL-9378-8]
FIFRA Scientific Advisory Panel; Notice of Public Meeting
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: There will be a 4-day meeting of the Federal Insecticide,
Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) to
consider and review the Endocrine Disruptor Screening Program (EDSP)
Tier 1 Screening Assays and Battery Performance.
DATES: The meeting will be held on May 21-24, 2013, from approximately
9 a.m. to 5 p.m.
Comments. The Agency encourages that written comments be submitted
by May 7, 2013 and requests for oral comments be submitted by May 14,
2013. However, written comments and requests to make oral comments may
be submitted until the date of the meeting, but anyone submitting
written comments after May 7, 2013 should contact the Designated
Federal Official (DFO) listed under FOR FURTHER INFORMATION CONTACT.
For additional instructions, see Unit I.C. of the SUPPLEMENTARY
INFORMATION.
Nominations. Nominations of candidates to serve as ad hoc members
of FIFRA SAP for this meeting should be provided on or before March 8,
2013.
Webcast. This meeting may be webcast. Please refer to the FIFRA
SAP's Web site, https://www.epa.gov/scipoly/sap for information on how
to access the webcast. Please note that the webcast is a supplementary
public process provided only for convenience. If difficulties arise
resulting in webcasting outages, the meeting will continue as planned.
Special accommodations. For information on access or services for
individuals with disabilities, and to request accommodation of a
disability, please contact the DFO listed under FOR FURTHER INFORMATION
CONTACT at least 10 days prior to the meeting to give EPA as much time
as possible to process your request.
ADDRESSES: The meeting will be held at the Environmental Protection
Agency, Conference Center, Lobby Level, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA 22202.
Comments. Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2013-0075, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave., NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.htm.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
If your comments contain any information that you consider to be
CBI or otherwise protected, please contact the DFO listed under FOR
FURTHER INFORMATION CONTACT to obtain special instructions before
submitting your comments.
Nominations, requests to present oral comments, and requests for
special accommodations. Submit nominations to serve as ad hoc members
of FIFRA SAP, requests for special seating accommodations, or requests
to present oral comments to the DFO listed under FOR FURTHER
INFORMATION CONTACT.
FOR FURTHER INFORMATION CONTACT: Fred Jenkins Jr., DFO, Office of
Science Coordination and Policy (7201M), Environmental Protection
Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001;
telephone number: (202) 564-3327; fax number: (202) 564-8382; email
address: jenkins.fred@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. This action may,
however, be of interest to persons who are or may be required to
conduct testing of chemical substances under the Federal Food, Drug,
and Cosmetic Act (FFDCA) and FIFRA. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities that may be affected by this action.
B. What should I consider as I prepare my comments for EPA?
When submitting comments, remember to:
1. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
2. Follow directions. The Agency may ask you to respond to specific
questions or organize comments by referencing a Code of Federal
Regulations (CFR) part or section number.
3. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
4. Describe any assumptions and provide any technical information
and/or data that you used.
5. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
6. Provide specific examples to illustrate your concerns and
suggest alternatives.
7. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
8. Make sure to submit your comments by the comment period deadline
identified.
C. How may I participate in this meeting?
You may participate in this meeting by following the instructions
in this unit. To ensure proper receipt by EPA, it is imperative that
you identify docket ID number EPA-HQ-OPP-2013-0075 in the subject line
on the first page of your request.
1. Written comments. The Agency encourages that written comments be
submitted, using the instructions in ADDRESSES, no later than May 7,
2013, to provide FIFRA SAP the time necessary to consider and review
the written comments. Written comments are accepted until the date of
the meeting, but anyone submitting written comments after May 7, 2013
should contact the DFO listed under FOR FURTHER INFORMATION CONTACT.
Anyone submitting written comments at the meeting should bring 25
copies for distribution to FIFRA SAP.
2. Oral comments. The Agency encourages that each individual or
group wishing to make brief oral comments to FIFRA SAP submit their
request to the DFO listed under FOR FURTHER INFORMATION CONTACT no
later than May 14, 2013, in order to be included on the meeting agenda.
Requests to present oral comments will be accepted until the date of
the meeting and, to the extent that time permits, the Chair of FIFRA
SAP may permit the presentation of oral comments at the meeting by
interested persons who have not previously requested time. The request
should identify the name of the individual making the presentation, the
organization (if any) the individual will
[[Page 12312]]
represent, and any requirements for audiovisual equipment (e.g.,
overhead projector, 35 mm projector). Oral comments before FIFRA SAP
are limited to approximately 5 minutes unless prior arrangements have
been made. In addition, each speaker should bring 25 copies of his or
her comments and presentation slides for distribution to the FIFRA SAP
at the meeting.
3. Seating at the meeting. Seating at the meeting will be open and
on a first-come basis.
4. Request for nominations to serve as ad hoc members of FIFRA SAP
for this meeting. As part of a broader process for developing a pool of
candidates for each meeting, FIFRA SAP staff routinely solicits the
stakeholder community for nominations of prospective candidates for
service as ad hoc members of FIFRA SAP. Any interested person or
organization may nominate qualified individuals to be considered as
prospective candidates for a specific meeting. Individuals nominated
for this meeting should have expertise in one or more of the following
areas: Regulatory toxicology/risk assessment, ecotoxicology (fish and
amphibian toxicology), comparative endocrinology, reproductive
physiology, developmental biology/toxicology, thyroid physiology, in
vitro models, toxicological pathology, amphibian histopathology,
morphometrics, quantitative ecology/biostatistics, and systems biology.
Nominees should be scientists who have sufficient professional
qualifications, including training and experience, to be capable of
providing expert comments on the scientific issues for this meeting.
Nominees should be identified by name, occupation, position, address,
and telephone number. Nominations should be provided to the DFO listed
under FOR FURTHER INFORMATION CONTACT on or before March 8, 2013. The
Agency will consider all nominations of prospective candidates for this
meeting that are received on or before this date. However, final
selection of ad hoc members for this meeting is a discretionary
function of the Agency.
The selection of scientists to serve on FIFRA SAP is based on the
function of the panel and the expertise needed to address the Agency's
charge to the panel. No interested scientists shall be ineligible to
serve by reason of their membership on any other advisory committee to
a Federal department or agency or their employment by a Federal
department or agency except the EPA. Other factors considered during
the selection process include availability of the potential panel
member to fully participate in the panel's reviews, absence of any
conflicts of interest or appearance of lack of impartiality,
independence with respect to the matters under review, and lack of
bias. Although financial conflicts of interest, the appearance of lack
of impartiality, lack of independence, and bias may result in
disqualification, the absence of such concerns does not assure that a
candidate will be selected to serve on FIFRA SAP. Numerous qualified
candidates are identified for each panel. Therefore, selection
decisions involve carefully weighing a number of factors including the
candidates' areas of expertise and professional qualifications and
achieving an overall balance of different scientific perspectives on
the panel. In order to have the collective breadth of experience needed
to address the Agency's charge for this meeting, the Agency anticipates
selecting approximately 10 ad hoc scientists.
FIFRA SAP members are subject to the provisions of 5 CFR part 2634,
Executive Branch Financial Disclosure, as supplemented by the EPA in 5
CFR part 6401. In anticipation of this requirement, prospective
candidates for service on the FIFRA SAP will be asked to submit
confidential financial information which shall fully disclose, among
other financial interests, the candidate's employment, stocks and
bonds, and where applicable, sources of research support. The EPA will
evaluate the candidates financial disclosure form to assess whether
there are financial conflicts of interest, appearance of a lack of
impartiality or any prior involvement with the development of the
documents under consideration (including previous scientific peer
review) before the candidate is considered further for service on FIFRA
SAP. Those who are selected from the pool of prospective candidates
will be asked to attend the public meetings and to participate in the
discussion of key issues and assumptions at these meetings. In
addition, they will be asked to review and to help finalize the meeting
minutes. The list of FIFRA SAP members participating at this meeting
will be posted on the FIFRA SAP Web site at https://www.epa.gov/scipoly/sap or may be obtained from the OPP Docket or at https://www.regulations.gov.
II. Background
A. Purpose of FIFRA SAP
FIFRA SAP serves as the primary scientific peer review mechanism of
EPA's Office of Chemical Safety and Pollution Prevention (OCSPP) and is
structured to provide scientific advice, information and
recommendations to the EPA Administrator on pesticides and pesticide-
related issues as to the impact of regulatory actions on health and the
environment. FIFRA SAP is a Federal advisory committee established in
1975 under FIFRA that operates in accordance with requirements of the
Federal Advisory Committee Act. FIFRA SAP is composed of a permanent
panel consisting of seven members who are appointed by the EPA
Administrator from nominees provided by the National Institutes of
Health and the National Science Foundation. FIFRA established a Science
Review Board consisting of at least 60 scientists who are available to
the SAP on an ad hoc basis to assist in reviews conducted by the SAP.
As a peer review mechanism, FIFRA SAP provides comments, evaluations
and recommendations to improve the effectiveness and quality of
analyses made by Agency scientists. Members of FIFRA SAP are scientists
who have sufficient professional qualifications, including training and
experience, to provide expert advice and recommendation to the Agency.
B. Public Meeting
Under the Federal Food, Drug, and Cosmetic Act (FFDCA), section
408(p) and the Safe Drinking Water Act (SDWA), section 1457, the EPA is
required to screen all pesticide chemicals (active and inert
ingredients) and those drinking water contaminants to which a
``substantial population'' is exposed for the potential to interact
with the endocrine system. As recommended by a Federal Advisory
Committee, (Endocrine Disruptor Screening and Testing Advisory
Committee, EDSTAC), the EPA Endocrine Disruptor Screening Program
(EDSP) established a two tiered screening and testing program to
address the potential of chemicals to perturb the estrogen, androgen or
thyroid (E,A or T) systems and elicit adverse human and ecological
health outcomes. In 1999, following the EDSTAC recommendations, a joint
subcommittee of the Agency's Science Advisory Board (SAB) and FIFRA SAP
recommended to the Agency, after review of the initial set of Tier 1
data, to subject that data to external scientific peer review for
consideration to further optimize the Tier 1 screening battery.
Tier 1 screening was recommended to include a diverse yet
complementary suite of in vitro and in vivo assays covering multiple
hormonal modes of action (MoA) across various taxa. To maximize
sensitivity and reliability (i.e., minimizing false negatives) for
determining the potential of a chemical to interact with E, A, or T,
the suite of assays was to be conducted as a battery.
[[Page 12313]]
If the results of the Tier 1 battery indicated the potential for a
chemical to interact with the endocrine system as determined through a
weight of evidence (WoE) analysis, various Tier 2 tests were to be
considered for determining dose-response relationships and any
potential adverse effects for risk assessment. The EDSP is mandated
under FFDCA to use ``validated'' assays to screen for endocrine
disrupting chemicals. Validation principles established by the
Organization for Economic Co-Operation and Development (OECD) and
Interagency Coordinating Committee on the Validation of Alternative
Methods (ICCVAM) were followed to develop, standardize, and validate
many of the initially proposed Tier 1 in vitro and in vivo screening
assays as well as more novel screening assays that emerged after the
EDSTAC final report in 1998. Subsequent to the validation process, an
independent peer review of individual Tier 1 screening assays was
conducted. Based on results of the validation process, comments from
peer review, and recommendations from EDSTAC, the EDSP proposed a
battery of screening assays that was founded on the strengths of one or
more assays complimenting the limitations of other assays in the
battery. Moreover, it was expected that the result(s) of each assay
would not be considered in isolation but be inclusive of the results of
all assays in the battery to support a WoE analysis. The FIFRA SAP
reviewed the proposed Tier 1 screening battery and recommended a
battery of 11 assays to EPA which the Panel indicated ``* * * as an
appropriate starting point to detect endocrine disrupting chemicals
based on the current state of the science.'' In addition, however, the
SAP also expected the Agency to continue ``* * * to develop, refine,
and review the battery.'' Notably, this latter statement concurs with a
recommendation from the initial joint SAB/SAP who indicated EPA should
review the initial data ``* * * with an eye towards revising the
process and eliminating those methods that don't work.''
This FIFRA SAP review will be focused on a subset of the initial
Tier 1 screening data received by the Agency in response to test orders
issued for the first list of chemicals in 2009. The SAP review will
involve the performance of the 11 Tier 1 screening assays and
performance of the assays as a battery that was designed to detect the
potential of a test chemical to interact with the E, A or T hormonal
pathways. The SAP will be asked to comment on factors that may impact
interpretation of the assay/battery results (e.g., variability) as well
as suggestions for increasing the efficiency of the Tier 1 screening
approach. To illustrate assay/battery performances, case examples of
Tier 1 data from the initial list of chemicals will be used. It should
be noted that there will be a separate SAP meeting scheduled in the
summer of 2013 to discuss the decision logic in a WoE approach to
identify candidate chemicals for Tier 2 testing using EDSP Tier 1
screening results, other scientifically relevant information (OSRI),
and health and ecological effects data from 40 CFR part 158 studies.
C. FIFRA SAP Documents and Meeting Minutes
EPA's background paper, related supporting materials, charge/
questions to FIFRA SAP, FIFRA SAP composition (i.e., members and ad hoc
members for this meeting), and the meeting agenda will be available by
approximately early May 2013. In addition, the Agency may provide
additional background documents as the materials become available. You
may obtain electronic copies of these documents, and certain other
related documents that might be available electronically, at https://www.regulations.gov and the FIFRA SAP homepage at https://www.epa.gov/scipoly/sap.
FIFRA SAP will prepare meeting minutes summarizing its
recommendations to the Agency approximately 90 days after the meeting.
The meeting minutes will be posted on the FIFRA SAP Web site or may be
obtained from the OPP Docket or at https://www.regulations.gov.
List of Subjects
Environmental protection, Pesticides and pests, and Endocrine
disruptors.
Dated: February 13, 2013.
Steven M. Knott,
Acting, Director, Office of Science Coordination and Policy.
[FR Doc. 2013-03977 Filed 2-21-13; 8:45 am]
BILLING CODE 6560-50-P